Efficacy and Safety of 177Lu-labeled Prostate-specific Membrane Antigen Radionuclide Treatment in Patients with Diffuse Bone Marrow Involvement: A Multicenter Retrospective Study — Andrei Gafita (2020) | RDL Network
Efficacy and Safety of 177Lu-labeled Prostate-specific Membrane Antigen Radionuclide Treatment in Patients with Diffuse Bone Marrow Involvement: A Multicenter Retrospective Study
Andrei Gafita, Wolfgang P. Fendler, Hui Wang, Shahneen Sandhu, Manuel Weber, Rouzbeh Esfandiari, Johannes Czernin, Hendrik Rathke, Isabel Rauscher, Robert Tauber, Ebrahim S. Delpassand, Wolfgang Weber, Ken Herrmann, Jérémie Calais, Matthias Eiber, Michael S. Hofman
Omar Alghazo, Renu Eapen, Nattakorn Dhiantravan, John Violet, Price Jackson, Mark Scalzo, Simon P. Keam, Catherine Mitchell, Paul J. Neeson, Shahneen Sandhu, Scott Williams, Daniel Moon, Nathan Lawrentschuk, Arun Azad, Michael S. Hofman, Declan G. Murphy
Discussion(0)
No comments yet. Be the first to comment.